Insider Transactions in Q3 2022 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2022
|
Phillip A Sharp Director |
SELL
Open market or private sale
|
Direct |
33,670
-50.35%
|
$7,710,430
$229.93 P/Share
|
|
Aug 15
2022
|
Phillip A Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
33,670
+29.91%
|
$1,548,820
$46.98 P/Share
|
|
Aug 05
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,841
-39.28%
|
$403,179
$219.65 P/Share
|
|
Aug 04
2022
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,002
-5.7%
|
$1,224,408
$204.92 P/Share
|
|
Aug 04
2022
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,052
-6.38%
|
$1,240,660
$205.35 P/Share
|
|
Aug 04
2022
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
5,086
-5.79%
|
$1,032,458
$203.89 P/Share
|
|
Aug 04
2022
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,054
-9.14%
|
$1,031,016
$204.99 P/Share
|
|
Aug 04
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,788
-26.52%
|
$357,600
$200.13 P/Share
|
|
Aug 03
2022
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,095
+16.28%
|
-
|
|
Aug 03
2022
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
13,183
+18.18%
|
-
|
|
Aug 03
2022
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
11,311
+16.81%
|
-
|
|
Aug 03
2022
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,325
+26.46%
|
-
|
|
Aug 03
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,754
-32.58%
|
$368,340
$210.0 P/Share
|
|
Aug 03
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,629
+40.27%
|
-
|
|
Jul 05
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,754
-50.0%
|
$263,100
$150.0 P/Share
|